Acadia Healthcare Q1 revenue up 7.6% to $828.8M; raises FY2026 guidance

Acadia Healthcare Company, Inc.

2026-Q1 EPS reported $0.05 revenue$828,802,000

Revenue $828.8M (+7.6% YoY); same-facility revenue +7.3%.
Adjusted EPS $0.37 vs $0.40 prior year; GAAP EPS $0.05 vs $0.09.
Adjusted EBITDA $144.2M vs $134.2M prior year (+7.5%).
Added 82 newly licensed beds in Q1; full-year adjusted EBITDA and EPS guidance raised.
Revenue per patient day +5.6%; patient days +1.6%.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Acadia Healthcare Company, Inc. reported the first quarter ended March 31, 2026 results: revenue $828.8 million, net income $0.05 per diluted share, EPS $0.05 per diluted share. Guidance raised.

Period: the first quarter ended March 31, 2026
Revenue: $828.8 million
Net income: $0.05 per diluted share
EPS: $0.05 per diluted share
Guidance: raised
Result: reported results

Exact text from the filing

Inc. (“Acadia” or the “Company”) (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2026. First Quarter 2026 Results ● Revenue totaled $828.8 million, a 7.6% increase compared with the first quarter of 2025 ● Same-facility revenue increased 7.3% compared with the first quarter of 2025, including an increase in revenue per

View on SEC.gov

1436 earnings releases filed in the last 30 days. Browse all earnings releases →

Acadia Healthcare Company, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-26-013916

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.